Novartis (NVS) Tops Q1 EPS by 2c

Novartis (NYSE: NVS) reported Q1 EPS of $1.46, $0.02 better than the analyst estimate of $1.44. Revenue for the quarter came in at $12.53 billion versus the consensus estimate of $12.73 billion.

Free cash flow of USD 0.9 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• Artisan Partners calls for board shake-up at Novartis after drug trial setbacks - Reuters
• Lahontan Gold names new CFO ahead of Santa Fe Mine restart
• Redwood Trust plans $150M convertible notes offering due 2030